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Abstract
Commonly used neuromodulation techniques such as electrical stimulation or 
pharmacologic intervention have some technical limitations that preclude dis-
secting particular cell- or pathway-specific functions in the brain, which is com-
posed of billions of neurons. An advancement of molecular genetics techniques 
has provided a novel method in neuroscience called optogenetics. Optogenet-
ics uses a combination of genetic and optical methods that provide a means 
to, with great temporal precision, experimentally control the activation or sup-
pression of specific neuronal sub-populations in heterogeneous brain regions 
where multiple neuronal subtypes exist; this approach can be performed even 
on freely moving animals. Thus, this tool can uniquely assist in establishing cau-
sality between the disorder and the underlying pathology. Ongoing explora-
tion of pathological mechanisms in various animal models of neuropsychiatric 
disorders with precise tools such as optogenetics can provide significant ad-
vances in the development of more focused approaches to treatment of these 
disorders. Here, we selectively highlight the major advancements gained by the 
use of optogenetic tools to uncover at circuit levels mechanisms relevant to 
neuropsychiatric disorders.
Keywords: optogenetics, opsin, neuropsychiatric disorders, addiction, schizo-
phrenia, stress, depression, Parkinson’s disease, Alzheimer’s disease.
Introduction
The brain is composed of billions of neurons which form uncountable connec-
tions, with each circuit having multiple cell types, firing properties, various sig-
naling events, and wiring patterns. Pathways of various compositions commu-
nicate in such a way that they not only control neighboring networks, but they 
are themselves controlled by surrounding circuits. Multiple neurotransmitters re-
leased with various patterns to activate postsynaptic receptors on other neurons 
are simultaneously involved in this complicated interaction. Since brain tissue has 
a heterogeneous nature, it is very difficult to define the role of specific neuronal 
types in intact circuits. However, for complete understanding of the pathology of 
brain disorders, it is necessary to identify the underlying particular neural cir-
cuits  using  precise  and  specific  methods and approaches. Despite the progress 
made in the last decades using various neuromodulation techniques (i.e. electri-
cal stimulation or pharmacologic intervention), many questions remain regard-
ing the exact circuitries and neurochemical mechanisms involved in certain path-
ological conditions. Indeed, it has been incredibly difficult to completely discern 
the underlying molecular mechanisms with these traditional tools, which are not 
able to dissect cell-type or pathway-specific function of a behavioral response. In 
fact, previous approaches either simultaneously affected multiple types of cells 
and processes in the targeted area, or had slow kinetics and reversibility.
Citation: Mikhailova, M., Deal, A., 
Budygin, E., and Gainetdinov, R. 2017. 
Optogenetics: Applications in neurobiology. 
Bio. Comm. 62(4): 261–271. https://doi.
org/10.21638/11701/spbu03.2017.405
Author’s information: Maria A. Mikhailova, 
Ph.D. student, orcid.org/0000-0002-
8710-6806; Alex L. Deal, Ph.D. student, 
orcid.org/0000-0003-0487-5720; 
Evgeny A. Budygin, Ph.D., Associate 
Professor, Principal Investigator, 
orcid.org/0000-0002-5675-0279; 
Raul R. Gainetdinov, M.D., Ph.D., Director, 
SCOPUS ID 7006340278, ResearcherID 
G-5875-2011
Manuscript Editor: Mikhail Kostylev, 
Department of Neurology, Yale University, 
USA;
Received: February 01, 2018; 
Revised: April 05, 2018; 
Accepted: April 13, 2018; 
Copyright: © 2017 Mikhailova et al. This 
is an open-access article distributed under 
the terms of the License Agreement with 
Saint Petersburg State University, which 
permits to the authors an unrestricted 
distribution and self-archiving free of 
charge.
Funding: This work was supported by 
the Russian Science Foundation (Grant 
no. 14-50-00069).
Competing interests: The author has 
declared that no competing interests exist.
262 BIOLOGICAL  COMMUNICATIONS,  vol. 62,  issue 4,  October–December,  2017 | https://doi.org/10.21638/11701/spbu03.2017.405
Advancement of molecular genetics has created 
revolutionary improvements in approaches study-
ing normal and pathological brain functioning. Since 
Karl Deisseroth and colleagues developed optogenetics 
via microbial opsin engineering by combining genetic 
methods and optical instruments for guiding light to ac-
tivate or inhibit the specific neural circuits to manipulate 
behavior with temporal precision, it has been widely ap-
plied in fundamental research of neural circuits involved 
in different kinds of behaviors and pathogenic mecha-
nisms of brain diseases (Boyden et al., 2005; Tye and De-
isseroth, 2012). The recent emergence of these tools pro-
vides a new effective approach for establishing the causal 
relationships between selective neuronal activity and be-
havior. Optogenetics uses a combination of genetic and 
optical methods to control the activity of specific cells 
of living tissue even within freely moving animals. This 
provides a means to experimentally control the activa-
tion or inhibition of specific neurons in heterogeneous 
brain regions where multiple neuronal sub-populations 
exist, and to do so with precise temporal resolution (De-
isseroth et al., 2006). Here, we will discuss the principal 
strengths of optogenetic manipulations to uncover at 
circuit levels the mechanisms relevant to certain neuro-
psychiatric disorders.
Optogenetic tools
Multiple components are required for a successful opto-
genetic study (Deisseroth, 2015). This technology most 
commonly involves three core features: microbial op-
sins (Berndt et al., 2011; Gradinaru et al., 2010; Mattis 
et al., 2011; Nagel et al., 2002, 2003; Zhang et al., 2007, 
2011), specific opsin gene expression which targets well-
defined cellular elements in the brain (Atasoy, Aponte, 
Su, and Sternson, 2008; Gradinaru et al., 2010; Kuhlman 
et al., 2008; Tsai et al., 2009), and neurochemical release 
in targeted brain regions elicited by certain wavelengths 
of light (Adamantidis et al., 2007; Aravanis et al., 2007; 
Bernstein et al., 2008; Diester et al., 2011; Grossman et 
al., 2010; Iwai et al., 2011; Schneider, Gradinaru, Zhang, 
and Deisseroth, 2008; Yizhar et al., 2011a).
Opsins, light-sensitive proteins, are a crucial tool 
for optogenetics. By inserting different exogenous light-
activated ion channels and pumps, neural circuits can 
be activated or inhibited in response to light depending 
upon the ion selectivity of the protein. Currently, the 
most widely applied opsin is a codon optimized form 
of Channelrhodopsin-2, ChR2(H134R). ChR2 is a blue-
light-activated cation channel from the single cell green 
alga Chlamydomonas reinhardtii (Nagel et al., 2003). 
When ChR2  is expressed in neurons, its activation by 
blue light opens the channel, thereby depolarizing the 
membrane, which allows sodium and potassium ions 
to flow down their electrochemical gradient into the 
cell. This blue light-activated cation channel allows 
millisecond-precision excitation of neurons (Nagel et al. 
2005; Towne and Thompson, 2016). Conversely, there is 
a microbial opsin that has been optimized to push the 
membrane voltage in the opposite direction and thus 
inhibit neural activity (Han et al., 2011; Stefaniket et 
al., 2013). Halorhodopsin, from the archaebacterium 
Natronomonas pharaonis (NpHR), is a yellow light-acti-
vated protein that pumps negative chloride ions into the 
cell, hyperpolarizing neural membranes and inhibiting 
activity (Zhang et al., 2007). Archaerhodopsin-3, from 
the archaebacterium Halorubrum sodomense (Arch), is 
a green light-activated protein that pumps protons out 
of the cell, also hyperpolarizing neural membranes and 
inhibiting activity (Chow et al., 2010). Together these 
three proteins comprise the basis of the majority of op-
togenetic studies reported in the literature.
The optogenetic opsin protein family is rapidly 
expanding. Newly found opsins are sensitive to higher 
wavelengths: yellow/red-shifted ChR types such as chan-
nelrhodopsin-1  from Volvox carteri (VChR1), a red-
shifted channelrhodopsin (ReaChR), and Chrimson are 
some of the recent ones (Klapoetke et al., 2014; Lin et al., 
2013; Zhang et al., 2008). These wavelengths are more 
suitable because they have less absorption and scattering 
in the brain tissue; therefore, they allow for the optical 
activation of particularly deep neurons (Lin et al., 2013).
Currently, genetic engineering methods enable the 
expression of these opsins in specific cell types and de-
sired subcellular locations. While the tools for achiev-
ing genetic specificity to opsin delivery are constantly 
improving, there are currently three general methods to 
transport opsins to neurons in vivo. The use of transgen-
ic mice, which stably express an opsin under the control 
of a specific promoter, is one of the common methods 
(Liske et al., 2013). The limitations of this method are 
the lack of spatial specificity of opsin expression and the 
time and effort required to generate new mouse lines 
for new opsins and promoters. Another approach is the 
use of viral vectors with neural tropism, such as lentivi-
rus and adeno-associated virus (AAV) (Fenno, Yizhar, 
and Deisseroth, 2011). These vectors can be engineered 
to express an opsin under the control of a specific pro-
moter, then injected into the brain region of interest, 
where they can be light-activated from a fiber optic cable 
guided to the area of infusion via a surgical implant. An 
advantage of this approach is that transgenic animals 
are not required, allowing delivery into species that are 
not easily amenable to transgenesis, such as rats and pri-
mates. The disadvantage of using vectors is that AAV is 
relatively small with a limited packaging capability, often 
cited as 4.7–5.4 kilobases (Grieger and Samulski, 2005), 
and cannot be used in targeting strategies that require 
large cell-type-specific promoters (Fitzsimons, Bland, 
and During, 2002). The final approach integrates the ad-
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vantages of transgenic mice with the brevity and preci-
sion targeting of viral methods. A large variety of mouse 
lines has been generated that expresses Cre-recombi-
nase under different cell-type-specific promoters. This 
recombinase recognizes loxP sites in DNA that flank a 
gene and can flip the sequence into the correct orienta-
tion to allow transcription (or vice versa). When a virus 
expressing an inverted and floxed (flanked by loxP sites) 
opsin is introduced into a Cre-recombinase expressing 
cell, the enzyme inverts the opsin into the correct ori-
entation to allow gene expression. Adjacent cells that 
do not express the Cre-recombinase are infected by the 
virus but do not express the opsin. By combining this 
with projection-based strategies, highly specific circuit 
targeting can be achieved (Towne and Thompson, 2016).
Optogenetic applications
The innovative application of opsin proteins for opto-
genetics has revolutionized many fields of biomedical 
research and particularly neuroscience. Therefore, it is 
not surprising that Nature Methods considered this ap-
proach the “Method of the Year” in 2010. The application 
of optogenetic methods has allowed us a more sophis-
ticated understanding of neuronal circuits underlying 
complex behaviors, such as those involved in psychiatric 
disorders.
Schizophrenia
Cortical inhibitory interneuron dysfunction may play 
an important role in the pathophysiology of certain psy-
chiatric disorders, including autism, schizophrenia and 
various cognitive disorders that are associated with so-
cial deficits (Benes, 2010; Marin, 2012; Rubenstein and 
Merzenich, 2003; Uhlhaas and Singer, 2010; Yizhar et 
al., 2011b; Yizhar, 2012). Schizophrenia symptoms in-
clude hallucinations, delusions, disorganized speech and 
catatonic behavior, as well as negative symptoms such as 
emotional flatness, apathy and lack of speech (Endicott 
and Spitzer, 1978; Kay, Fszbein, and Opler, 1987).
With its complex cytoarchitecton structure, the 
neocortex contains multiple neuronal subtypes, includ-
ing distinct classes of inhibitory interneurons and excit-
atory pyramidal neurons (Freund, 2003; Isaacson and 
Scanziani, 2011; Markram et al., 2004). Optogenetics 
allows for a clearly defined way to distinguish between 
these functionally discrete cell types and to record and 
manipulate neural activity in a precise way, unlike elec-
trical stimulation. The breakdown in the transmission 
or processing of neural information is one symptom 
of schizophrenia, which is thought to be correlated to 
an imbalance between excitation and inhibition, there-
fore altering gamma oscillations, which are considered 
to have a potential role in the transfer of information 
between brain regions (Kehrer, Maziashvili, Dugladze, 
and Gloveli, 2008; Lewis, Hashimoto, and Volk, 2005). 
A specific class of GABA interneurons that express the 
calcium-binding protein parvalbumin (PV) and have 
fast-spiking (FS) electrophysiological properties is 
widely believed to generate cortical gamma oscillations 
(Freund T., 2003; Fuchs et al., 2007; Sohal, 2012; Tamas, 
Buhl, Lorincz, and Somogyi, 2000; Whittington, Traub, 
and Jefferys, 1995; Ylinen et al., 1995). Traditional neu-
robiological methods made it difficult to selectively ma-
nipulate PV neurons; however, optogenetic tools allow 
us to control PV neuron activity on a millisecond time 
scale.
Two recent studies used optogenetics to directly 
test the role of PV neurons. Cardin et al. showed that 
optically-induced activation of PV interneurons at 40–
50 Hz is sufficient to induce gamma frequency local field 
potential (LFP) oscillations, while activation of pyrami-
dal neurons enhanced only lower frequency oscillations 
and did not elicit LFP gamma oscillations in the barrel 
cortex of PV-Cre mice (Cardin et al., 2009). Gamma fre-
quency modulation of excitatory input was also found 
to heighten cortical circuit performance by reducing 
circuit noise (Cardin et al., 2009; Sohal et al., 2009). Ad-
ditionally, this study showed that gamma frequency LFP 
oscillations generated by PV interneurons can gate sen-
sory inputs, demonstrating a potential role for interneu-
ron-driven oscillations in cortical processing. Next, us-
ing an array of optogenetic technologies (Aravanis et al., 
2007; Boyden et al., 2005; Zhang et al., 2007), Deisseroth 
and his group have demonstrated that inhibition of PV 
interneurons via halorhodopsin (eNpHR) suppresses 
gamma oscillations, whereas activation of these neurons 
drives gamma oscillations in vivo (Sohal et al., 2009). 
These two studies have clearly revealed the ability of PV 
neurons to generate cortical gamma rhythms and their 
role in information processing in the neocortex, which 
may help to understand information processing deficits 
in schizophrenia (Cardin et al., 2009; Sohal et al., 2009).
Severe behavioral deficits in psychiatric diseases 
such as schizophrenia have been hypothesized to arise 
from a disruption in the homeostatic balance between 
cortical excitation and inhibition (E/I balance), possi-
bly reflecting mechanisms such as impairments in PV 
interneurons within neural microcircuitry (Kehrer, Ma-
ziashvili, Dugladze, and Gloveli, 2008; Markram et al., 
2010; Rubenstein and Merzenich, 2003; Rubenstein et 
al., 2010; Vattikuti et al., 2010). Yizhar et al. tested this 
hypothesis in freely moving mice using several optoge-
netic tools. This study found that increasing activity in 
excitatory neurons within the medial prefrontal cortex 
disrupted the social behavior of mice, whereas optoge-
netically elevating activity within prefrontal interneu-
rons did not. Thus, elevation, but not reduction, of cellu-
lar E/I balance elicits a profound impairment in cellular 
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information processing associated with specific behav-
ioral impairments (Yizhar et al., 2011b).
Addiction
Optogenetics has importantly contributed to investiga-
tion of the neuronal pathways related to reward seeking, 
and has allowed identification of the adaptations that 
take place in these circuits following chronic exposure to 
drugs of abuse (Cao, Burdakov, and Sarnyai, 2011; Lobo, 
2012; Stuber, Britt, and Bonci, 2012).
Two highly interconnected brain regions play criti-
cal roles in mediating reward: the ventral tegmental area 
(VTA) and the nucleus accumbens (NAc). The VTA is a 
heterogeneous brain structure that contains different neu-
ronal populations, which include dopamine (DA), GABA 
and glutamate neurons. DA neurons in the VTA are the 
main effectors of reward (Berke and Hyman, 2000; Grace, 
2000; Gonzales, Job, and Doyon, 2004; Stuber, Britt, and 
Bonci, 2012; Weiss and Porrino, 2002). It is well known 
that DA can be released naturally with two main patterns: 
phasic and tonic (Grace, 1991; Grace, 2000; Schultz, 1998; 
Wightman and Robinson, 2002). Tonic DA firing occurs 
at a low frequency of 5–10 Hz and results in steady-state 
DA concentrations that are lower than 50  nM (Justice, 
1993; Parsons and Justice, 1992). In contrast, phasic, or 
burst, firing of DA neurons at frequencies of more than 
30 Hz leads to large, transient increases in DA concen-
trations, which may significantly exceed 50 nM (Aragona 
et al., 2008; Freeman, Meltzer, and Bunney, 1985; Grace 
and Bunney, 1983, 1984; Hyland et al., 2002; Wightman 
and Robinson, 2002; Wightman and Zimmerman, 1990). 
These distinct characteristics of phasic and tonic DA re-
lease suggest divergent roles of each pattern in the con-
trol of DA-related behaviors. Recently, the emergence of 
optogenetics has allowed us to better explore the causal 
relationship between accumbal DA and addictive behav-
ior. Optogenetic activation of VTA DA neurons can selec-
tively induce DA release in accumbal terminal fields with 
very high temporal and spatial precision. Moreover, opti-
cal stimulation of the VTA was shown to mimic phasic 
and tonic DA release (Bass et al., 2013; Tsai et al., 2009). 
Using a combinatorial viral-mediated gene delivery ap-
proach to express ChR2  in mesolimbic DA neurons in 
rats, our group revealed that tonic optogenetic stimula-
tion of VTA-nucleus accumbens DA release significantly 
decreased reward consummatory behavior, possibly by 
masking phasic activity that is thought to be essential for 
reward-based behaviors (Bass et al., 2013; Mikhailova et 
al., 2016). Using the same approach, Tsai and his group 
showed that phasic, but not tonic, DA release is solely re-
sponsible for the development of conditional place prefer-
ence (CPP) (Tsai et al., 2009).
These results demonstrate that phasic DA activity 
is sufficient to mediate behavioral conditioning (Tsai et 
al., 2009). Furthermore, phasic activation of DA neu-
rons causally enhances positive reinforcing actions in a 
food-seeking task (Adamantidis et al., 2011). Moreover, 
phasic activation was sufficient to reactivate previously 
extinguished food-seeking behavior in the absence of 
external cues (Adamantidis et al., 2011) and to enhance 
the initiation of approach behavior without long-term 
motivational regulation (Ilango et al., 2014). Optoge-
netic activation of DA neurons, mimicking a prediction 
error, was sufficient to cause long-lasting increases in 
cue-elicited, reward-seeking behavior (Steinberg et al., 
2013).
The notion that changes in excitatory drive onto NAc 
neurons is central to drug effects is further strengthened 
by studies that have directly manipulated the activity of 
D1 dopamine receptor (D1R) or D2 dopamine receptor 
(D2R) containing MSNs (Bock et al., 2013; Lobo et al., 
2010) or the cholinergic interneuron populations within 
the NAc (Witten et al., 2010). Lobo et al. used optoge-
netic tools to selectively control the firing rate of D1R 
and D2R neurons in the NAc and studied consequent 
effects on cocaine reward. This study showed that D1R 
and D2R containing neurons in the NAc have distinctly 
different effects on cocaine conditioned place prefer-
ence: activating D1R-expressing neurons enhances co-
caine CPP, whereas activating D2R-expressing neurons 
suppresses cocaine CPP (Lobo et al., 2010). These results 
provide insight into the molecular control of D1R and 
D2R neuronal activity as well as the circuit level contri-
bution of these cell types to cocaine reward (Lobo et al., 
2010). Optogenetic methods helped to establish the role 
of cholinergic cells, despite the fact that they represent 
less than 1% of NAc neurons (Witten et al., 2010). In 
related work that also combined optogenetics with the 
use of CPP, it has been shown that light-induced silenc-
ing of cholinergic neurons in the NAc blocked cocaine 
conditioning in freely moving mammals.
Stuber et al. demonstrated that optical stimulation 
of the excitatory projections from the BLA to the NAc, 
but not cortical projections, in mice produced robust 
self-stimulation. Moreover, this self-stimulation of BLA-
NAc projections was dependent on D1R signalling. Brief 
optical inhibition of BLA-to-NAc fibers reduced cue-
evoked intake of sucrose, demonstrating an important 
role of this specific pathway in controlling naturally oc-
curring reward-related behavior. These data suggest that 
while the BLA is important for processing both positive 
and negative effects, the BLA-to-NAc glutamate pathway 
in conjunction with DA signaling in the NAc promotes 
motivated behavioral responding (Stuber, Britt, and 
Bonci, 2011). Optogenetic self-stimulation of DA neu-
rons in the VTA has also been demonstrated (Adaman-
tidis et al., 2011; Witten et al., 2011). Cohen et al. showed 
that activation of VTA GABA neurons inhibits VTA DA 
neurons in vivo and counteracts excitatory drive from 
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primary reward when the reward is expected. In ad-
dition, these neurons were excited by aversive stimuli, 
potentially contributing to suppression of firing in some 
DA neurons in response to aversive events (Cohen et 
al., 2012). Research is also underway to understand why 
drug-seeking behaviors persist despite severe adverse 
consequences, which is a hallmark of addiction (Chen 
et al., 2013; Seif et al., 2013). Chen et al. indicated that 
cocaine self-administration decreases ex vivo intrinsic 
excitability of deep layer pyramidal neurons in the pre-
limbic cortex, which was significantly more pronounced 
in compulsive drug-seeking animals. Furthermore, 
compensating for hypoactive prelimbic cortex neurons 
with in vivo optogenetic prelimbic cortex stimulation 
significantly prevented compulsive cocaine seeking, 
whereas optogenetic prelimbic cortex inhibition signifi-
cantly increased compulsive cocaine seeking (Chen et 
al., 2013). Together, these studies clearly demonstrate 
how optogenetics has revealed the causality of changes 
in brain neurotransmission for addictive behaviors and 
has begun to identify related circuitries.
Stress and Anxiety
Commonly comorbid with addiction, stress-related dis-
orders can influence reward seeking and reward taking 
behavior and have been similarly explored using opto-
genetics. Anxiety disorders are a result of aberrant stress 
responses characterized by a hyper-alert state of arousal 
which can be exhibited as a multitude of varied symp-
toms (Lieb, 2005). Due to the diverse manifestations of 
anxiety disorders, understanding the underlying circuit-
ry driving these stress-related behaviors is an important 
step towards effectively treating them.
A group of regions that has garnered close exami-
nation in stress and anxiety disorders includes the shell 
region of the NAc, the bed nucleus of the stria termina-
lis (BNST), and the medial (MeA), central (CeA), and 
basolateral (BLA) nuclei of the amygdala (sometimes 
refered to as the “extended amygdala”; Sparta, Jennings, 
Ung, and Stuber, 2013). The BNST, in particular, has 
been the focus of numerous optogenetic studies (Garcia-
Garcia et al., 2017; Partridge et al., 2016; Xu et al., 2016) 
due to its connectivity to both stress regions, particularly 
the amygdala, and regions involved in reward, such as 
the mesolimbic pathway (Sparta Jennings, Ung, and Stu-
ber, 2013). For example, it was shown that modulation 
of BNST GABA inputs can occur when optically stimu-
lated in the presence of an agonist for kappa opioid re-
ceptors, which play a role in stress-induced behavioral 
changes (Li et al., 2012). While some studies show that 
stress and stress-induced signaling can lead to changes 
in neuronal activity, other regions studied have demon-
strated that neuronal activation can induce stress and 
anxiety-like behavior. It was recently found that optical 
activation of β-adrenergic receptor signaling via Gαs in 
BLA excitatory neurons was able to induce anxiety-like 
behaviors in mice (Siuda et al., 2016). These experiments 
show that the application of optogenetics can enable sci-
entists to explore the effects of stressful stimuli on neu-
ronal function but also the effects of neuronal function 
on behavior displays, whether in the presence of a stress-
ful stimuli or not.
Other regions and pathways have also been exam-
ined in stress and anxiety disorders, including structures 
with connections to the amygdala such as the medial pre-
frontal cortex (mPFC), locus coeruleus (LC), and hip-
pocampus (Felix-Ortiz et al., 2016; Luthi and Luscher, 
2014; McCall et al., 2015; Seo et al, 2016; Vialou et al., 
2014), as well as other circuitry such as the septohypo-
thalamic circuit (Anthony et al., 2015). The LC is of par-
ticular interest because of its prominent role in the stress 
response. It was found that optically-induced corticotro-
pin releasing hormone (CRH) release from projections 
from the amygdala to the LC resulted in anxiogenic be-
havior (McCall et al., 2015). Alternatively, optical stimu-
lation of LC noradrenergic terminals in the BLA also in-
duced anxiety-like behavior (McCall et al., 2017). Inter-
estingly, studies have been able to take advantage of the 
specificity of optogenetics to target distinct efferent and 
afferent projections between the two regions. For exam-
ple, optical stimulation of projections from the mPFC 
to the BLA inhibited cholecystokinin-induced anxiety 
(Vialou et al., 2014), while optical stimulation of inputs 
from the BLA to the mPFC was also anxiogenic (Felix-
Ortiz et al., 2016). This is important because the ability 
to isolate projections and induce precise activation (or 
inhibition) can help establish causality in connecting the 
circuit of activity within these regions of interest with 
the related stress and anxiety-like behavior.
Depression
Depression is a common mental disorder characterized 
by persistent sadness and a loss of interest in activities 
(Kessler et al., 2003). The major behavioral symptoms 
include anhedonia and deficits in several aspects of re-
ward. This suggests a certain degree of overlap among 
the brain regions affected by depression and drug addic-
tion (Russo et al., 2013).
One experiment elicited a depression-related phe-
notype (increased social avoidance and decreased su-
crose preference) in mice undergoing a subthreshold 
social defeat paradigm with optogenetic phasic activa-
tion of VTA DA neurons (Chaudhury et al., 2013). Ac-
tivation of these neurons also quickly induced a similar 
phenotype in previously resilient mice that had been 
subjected to repeated social defeat stress (Chaudhury 
et al., 2013). Furthermore, the differences in projection 
pathway-specificity in promoting stress susceptibility 
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were shown: optical activation of NAc-projecting or in-
hibition of PFC-projecting VTA DA neurons induced 
susceptibility to social-defeat stress (Chaudhury et al., 
2013). In contrast to these results, following a chronic 
mild stress protocol, which is different from the acute 
social defeat stress, optogenetic phasic activation of VTA 
DA neurons acutely rescued the chronic mild stress-in-
duced depression-like phenotype and alleviated deficits 
in sucrose preference assays while selective inhibition of 
VTA DA neurons acutely produced depression-related 
behavior in freely moving rodents (Tye et al., 2012).
Two other key brain areas of depression-related 
circuitry that have been targeted using optogenetics are 
the mPFC and dorsal raphe (DR). The mPFC contains 
different neuronal populations, and it is believed that 
this structure plays an important role in various neuro-
psychiatric diseases, including depression. However, an 
understanding of the mechanisms by which the mPFC 
neurons are involved in this disorder has remained elu-
sive. A series of optogenetic studies were carried out to 
investigate the role of different classes of mPFC neurons 
in depression-related behavior. Covington et al. (2010) 
performed the first optogenetic study of the mPFC in a 
mouse model of depression and showed that optogenetic 
activation of the mPFC induced an antidepressant-like 
effect in susceptible mice following chronic social defeat 
stress. Activation of mPFC terminals in the brainstem 
DR nucleus increased motor activity during the forced 
swim test, but did not affect general locomotor activ-
ity in the open field test, suggesting that this projection 
is particularly important for responding to behavioral 
challenges (Warden et al., 2012). Further work revealed 
that activation of mPFC terminals in the NAc generated 
antidepressant-like effects following social defeat stress, 
whereas mPFC terminal activation in the BLA had anx-
iolytic effects (Vialou et al., 2014).
Parkinson’s disease
Parkinson’s disease (PD), a common neurodegenera-
tive disease, is characterized by rigidity, tremor, postural 
instability and slow movement (Gelb, Oliver, and Gil-
man, 1999; Hughes, Daniel, Kilford, and Lees, 1992). 
PD results from the death of dopamine neurons in the 
substantia nigra (SN). Pharmacological approaches 
to elevate DA levels and deep brain stimulation (DBS) 
have been the conventional treatments for PD for many 
decades. Pharmacological interventions, however, have 
various limitations and side effects following long-term 
use. Although DBS in the subgenual cingulate cortex 
has been used in humans to treat depression (Mayberg 
et al., 2005), DBS in the subthalamic nucleus (STN), a 
part of the basal ganglia circuit, and in other targets, has 
shown some therapeutic effects for treatment of the mo-
tor mainfestations of Parkinson’s disease (Benabid, 2003; 
Deuschl et al., 2006; Kumar et al., 1998). However, the 
precise cellular mechanisms of this therapy have been 
unclear and highly controversial. Because of the hetero-
geneity of brain tissue where electrodes are placed, it has 
been challenging to elucidate the major target cell types 
involved or the underlying mechanisms of DBS. 
In 2009, it was reported that therapeutic effects 
could be accounted for by direct and selective stimula-
tion of afferent axons projecting into the STN using op-
togenetics and solid-state optics to drive or inhibit an ar-
ray of distinct circuit elements in freely moving parkin-
sonian rodents (Gradinaru et al., 2009). High-frequency 
stimulation of afferent fibers projecting from the motor 
cortex to the STN ameliorated motor symptoms, while 
optogenetic excitation and inhibition of subthalamic 
nucleus neurons had no effect. Thus, these results dem-
onstrated an optical approach for dissection of disease 
circuitry and provided a new way for systematic decon-
struction of disease circuits by selectively controlling 
individual components (Gradinaru et al., 2009). These 
data suggested a model for DBS treatment in which 
white matter tracts or axonal pathways are the most ef-
fective direct target of control. These data were later con-
firmed by other studies (Li et al., 2012).
Optogenetics has also been used to probe the 
mechanisms underlying the efficacy of grafting human 
pluripotent stem cell-derived DA neurons in disease 
models. Animals with striatal 6-OHDA lesions exhibit 
motor impairments that are strongly reversed following 
engraftment of DA neurons in the lesioned area (Kriks 
et al., 2011). To probe the mechanisms underlying the 
efficacy of this effect, Steinbeck et al. optogenetically 
inhibited engrafted DA stem cells after motor recovery. 
They reported that inhibiting DA neurons resulted in 
the reappearance of motor deficits, indicating the essen-
tial role of DA neurons at the lesion site (Steinbeck et 
al., 2015).
Alzheimer’s disease
Alzheimer’s disease (AD) is the debilitating neurodegen-
erative disorder most commonly observed in the elderly, 
in which patients have problems with language, disori-
entation, and impaired declarative memory that affects 
neuronal activity at many levels. AD is the most com-
mon form of dementia that results from damage of neu-
rons and local circuits in specific brain regions (Palop et 
al., 2006). The aggregation of amyloid β (Aβ) peptides is 
considered one of the hallmarks of this pathological dys-
function in the brains of AD patients (Selkoe et al., 2012). 
Studies using electrical or pharmacological stimulations 
have shown that certain patterns of neuronal activity 
can modulate the formation and secretion of Aβ plaques 
from neurons (Cirrito et al., 2005, 2008; Kamenetz et al., 
2003), however, the exact mechanism of this phenom-
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enon remains largely unknown. Optogenetics was used 
to selectively activate a specific neuronal pathway in APP 
transgenic mice in order to observe the causative role 
between a certain type of synaptic activation and Aβ pa-
thology (Yamamoto et al., 2015). Their findings suggest 
a connection between overactivity of the specific projec-
tion pathway and augmentation in Aβ deposition. This 
study also provided the foundation for further research 
using optogenetics for chronic stimulation in animal 
models of neurodegenerative disorders. 
Long-term memory is essential for cognition, and its 
disruption is pivotal to multiple neurolpsychiatric disor-
ders, especially AD. Bero et al. found that optogenetic ex-
citation of mPFC neurons inhibits the activation of ento-
rhinal-hippocampal circuits and impairs the encoding of 
long-term associative memory (Bero et al., 2014). Since 
the development of optogenetics, there have also been 
some new discoveries about the mechanism of memory 
retrieval. It was found that contextual fear memory re-
call could be abolished by optogenetic inhibition of the 
hippocampus, but could not be influenced by pharma-
cological inhibition. It indicated that long-term memory 
retrieval, which is dependent on the hippocampus, could 
shift to other structures like the anterior cingulate cortex 
(Goshen et al., 2011; Rajasethupathy et al., 2015).
Conclusion
The use of optogenetics has greatly improved the preci-
sion with which we are able to examine discrete neuro-
nal subpopulations in a cell- and time-specificic manner 
unattainable through conventional methods. Further-
more, this tool can uniquely be used to establish cau-
sality between the disorder and the underlying biology. 
As we examine different neuropsychiatric disorders with 
precise tools such as optogenetics, the accumulated data 
will guide the future development of new therapeutic 
approaches that will become more focused.
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